Biotech
Alexion Pharmaceuticals
Alexion Pharmaceuticals raises $40B Public at $42B valuation
$40B
Total Raised
Public
Latest Round
1992
Founded
3500+
Employees
121 Seaport Boulevard, Boston, MA 02210
1 min read
Quick Facts
Valuation
$42B
Latest Round Size
$40B
Latest Round Date
January 2024
Alexion Pharmaceuticals: Public Funding Round
Alexion Pharmaceuticals has successfully raised $40B in Public funding, reaching a valuation of $42B.
Company Overview
Biopharmaceutical company
Funding Details
The Public round was led by AstraZeneca.
Company Information
- Headquarters: 121 Seaport Boulevard, Boston, MA 02210
- Founded: 1992
- Employees: 3500+
- Category: Biotech
Investment
Alexion Pharmaceuticals plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- AstraZeneca: Verified investor in Public
Key Investors
AstraZeneca
Lead Investor
Verified investor in Public
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M